GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » DuoGenic StemCells Corp (ROCO:7607) » Definitions » Total Inventories

DuoGenic StemCells (ROCO:7607) Total Inventories : NT$4.68 Mil (As of Jun. 2024)


View and export this data going back to 2023. Start your Free Trial

What is DuoGenic StemCells Total Inventories?

DuoGenic StemCells's total inventories for the quarter that ended in Jun. 2024 was NT$4.68 Mil. DuoGenic StemCells's average total inventories from the quarter that ended in Dec. 2023 to the quarter that ended in Jun. 2024 was NT$8.25 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. DuoGenic StemCells's Net-Net Working Capital per share for the quarter that ended in Jun. 2024 was NT$0.37.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. DuoGenic StemCells's Days Inventory for the six months ended in Jun. 2024 was 363.15.

Inventory Turnover measures how fast the company turns over its inventory within a year. DuoGenic StemCells's Inventory Turnover for the quarter that ended in Jun. 2024 was 0.50.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. DuoGenic StemCells's Inventory-to-Revenue for the quarter that ended in Jun. 2024 was 1.62.


DuoGenic StemCells Total Inventories Historical Data

The historical data trend for DuoGenic StemCells's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DuoGenic StemCells Total Inventories Chart

DuoGenic StemCells Annual Data
Trend Dec21 Dec22 Dec23
Total Inventories
2.67 5.72 11.82

DuoGenic StemCells Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Total Inventories Get a 7-Day Free Trial - 5.72 5.66 11.82 4.68

DuoGenic StemCells Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.


DuoGenic StemCells  (ROCO:7607) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

DuoGenic StemCells's Net-Net Working Capital Per Share for the quarter that ended in Jun. 2024 is

Net-Net Working Capital Per Share (Q: Jun. 2024 )
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(20.315+0.75 * 2.988+0.5 * 4.684-13.661
-0-0)/30.553
=0.37

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

DuoGenic StemCells's Days Inventory for the six months ended in Jun. 2024 is calculated as:

Days Inventory=Average Total Inventories (Q: Jun. 2024 )/Cost of Goods Sold (Q: Jun. 2024 )*Days in Period
=8.254/4.148*365 / 2
=363.15

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

DuoGenic StemCells's Inventory Turnover for the quarter that ended in Jun. 2024 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Jun. 2024 ) / Average Total Inventories (Q: Jun. 2024 )
=4.148 / 8.254
=0.50

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

DuoGenic StemCells's Inventory to Revenue for the quarter that ended in Jun. 2024 is calculated as

Inventory-to-Revenue=Average Total Inventories (Q: Jun. 2024 ) / Revenue (Q: Jun. 2024 )
=8.254 / 5.092
=1.62

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.


DuoGenic StemCells Total Inventories Related Terms

Thank you for viewing the detailed overview of DuoGenic StemCells's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.


DuoGenic StemCells Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Room R207, Innovation Incubation Center, 145, Xingda Road, South District, Taichung, TWN
DuoGenic StemCells Corp is a company having a team of passionate researchers focused on stem cell cultivation. Their products are intended for research use and can be upgraded for clinical applications. It also develops blood cell therapy programs, using the isolation and purification of blood mononuclear cells to remove granule cells that promote inflammation, and conducts clinical trials on various degenerative diseases to provide a convenient and simple new option for cell therapy.

DuoGenic StemCells Headlines

No Headlines